If anyone has understood something about the Doliprane serial, it would be kind to explain to me the why and how and vice versa (write to the newspaper, which will transmit it). At the point where things are, it would seem, if I try to summarize the previous, current and possibly future episodes, that the painkiller manufactured in France by Sanofi would be bought by Americans, but that the French would keep control of it, it being understood that the Americans would be the sole owners, while allowing the French to exercise their right of review, and perhaps even of veto, provided that the Americans could do with it what they want, without of course harming French interests, guaranteed by the Americans, who will indeed have the right to act as they see fit, within the limits of preserving the decision-making autonomy of the French within a perimeter controlled by the Americans, in respect of possible decisions of the French concerning possible possible developments, provided, of course, of maintaining the minimum level of added value produced for five years, although this formula, which I have copied as it is, means.
We see from this that everything is going for the best, even if the best is the enemy of the good, and if the good is the friend of the best, especially after a pill of Doliprane, in the mutual interest of possibly hypothetical reciprocal benefits .